diquafosol has been researched along with sar 1118 in 1 studies
| Studies (diquafosol) | Trials (diquafosol) | Recent Studies (post-2010) (diquafosol) | Studies (sar 1118) | Trials (sar 1118) | Recent Studies (post-2010) (sar 1118) |
|---|---|---|---|---|---|
| 126 | 38 | 92 | 43 | 10 | 42 |
| Protein | Taxonomy | diquafosol (IC50) | sar 1118 (IC50) |
|---|---|---|---|
| Integrin beta-2 | Homo sapiens (human) | 0.0415 | |
| Intercellular adhesion molecule 1 | Homo sapiens (human) | 0.0287 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 3 | |
| Integrin alpha-L | Homo sapiens (human) | 0.0415 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, S; Kim, CE; Kim, K; Kleinman, HK; Ousler, GW; Sosne, G; Yang, J | 1 |
1 other study(ies) available for diquafosol and sar 1118
| Article | Year |
|---|---|
RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model.
Topics: Animals; Conjunctiva; Cornea; Cyclosporine; Disease Models, Animal; Dry Eye Syndromes; Female; Goblet Cells; Humans; Inflammation Mediators; Lacrimal Apparatus; Male; Mice; Mice, Inbred NOD; Mucins; Ophthalmic Solutions; Phenylalanine; Polyphosphates; Prescription Drugs; Scopolamine; Sulfones; Tears; Thymosin; Treatment Outcome; Uracil Nucleotides | 2018 |